Okkenhaug K - Search Results

1

Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages.

Leverrier Y, Okkenhaug K, Sawyer C, Bilancio A, Vanhaesebroeck B, Ridley AJ. Leverrier Y, et al. Among authors: okkenhaug k. J Biol Chem. 2003 Oct 3;278(40):38437-42. doi: 10.1074/jbc.M306649200. Epub 2003 Jul 16. J Biol Chem. 2003. PMID: 12869549 Free article.

2

Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release.

Stewart H, Palmulli R, Johansen KH, McGovern N, Shehata OM, Carnell GW, Jackson HK, Lee JS, Brown JC, Burgoyne T, Heeney JL, Okkenhaug K, Firth AE, Peden AA, Edgar JR. Stewart H, et al. Among authors: okkenhaug k. EMBO Rep. 2023 Dec 6;24(12):e57224. doi: 10.15252/embr.202357224. Epub 2023 Oct 11. EMBO Rep. 2023. PMID: 37818801 Free PMC article.

3

Tissue-resident B cells orchestrate macrophage polarisation and function.

Suchanek O, Ferdinand JR, Tuong ZK, Wijeyesinghe S, Chandra A, Clauder AK, Almeida LN, Clare S, Harcourt K, Ward CJ, Bashford-Rogers R, Lawley T, Manz RA, Okkenhaug K, Masopust D, Clatworthy MR. Suchanek O, et al. Among authors: okkenhaug k. Nat Commun. 2023 Nov 4;14(1):7081. doi: 10.1038/s41467-023-42625-4. Nat Commun. 2023. PMID: 37925420 Free PMC article.

4

New responsibilities for the PI3K regulatory subunit p85 alpha.

Okkenhaug K, Vanhaesebroeck B. Okkenhaug K, et al. Sci STKE. 2001 Jan 16;2001(65):pe1. doi: 10.1126/stke.2001.65.pe1. Sci STKE. 2001. PMID: 11752634 Review.

5

Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.

Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield MD, Smith AJ, Vanhaesebroeck B. Okkenhaug K, et al. Science. 2002 Aug 9;297(5583):1031-4. doi: 10.1126/science.1073560. Epub 2002 Jul 18. Science. 2002. PMID: 12130661

6

PI3K-signalling in B- and T-cells: insights from gene-targeted mice.

Okkenhaug K, Vanhaesebroeck B. Okkenhaug K, et al. Biochem Soc Trans. 2003 Feb;31(Pt 1):270-4. doi: 10.1042/bst0310270. Biochem Soc Trans. 2003. PMID: 12546700 Review.

7

PI3K in lymphocyte development, differentiation and activation.

Okkenhaug K, Vanhaesebroeck B. Okkenhaug K, et al. Nat Rev Immunol. 2003 Apr;3(4):317-30. doi: 10.1038/nri1056. Nat Rev Immunol. 2003. PMID: 12669022 Review.

8

Gene-targeting reveals physiological roles and complex regulation of the phosphoinositide 3-kinases.

Foukas LC, Okkenhaug K. Foukas LC, et al. Among authors: okkenhaug k. Arch Biochem Biophys. 2003 Jun 1;414(1):13-8. doi: 10.1016/s0003-9861(03)00177-2. Arch Biochem Biophys. 2003. PMID: 12745249 Review.

9

Phosphoinositide 3-kinase in T cell activation and survival.

Okkenhaug K, Bilancio A, Emery JL, Vanhaesebroeck B. Okkenhaug K, et al. Biochem Soc Trans. 2004 Apr;32(Pt 2):332-5. doi: 10.1042/bst0320332. Biochem Soc Trans. 2004. PMID: 15046602 Review.

10

Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing.

Reif K, Okkenhaug K, Sasaki T, Penninger JM, Vanhaesebroeck B, Cyster JG. Reif K, et al. Among authors: okkenhaug k. J Immunol. 2004 Aug 15;173(4):2236-40. doi: 10.4049/jimmunol.173.4.2236. J Immunol. 2004. PMID: 15294934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters